Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Suicidal thoughts and behaviours during antidepressant treatment, especially during the first weeks of treatment, have prompted warnings by regulatory bodies. The aim of the present study is to investigate the course and predictors of emergence and worsening of suicidal ideation during tricyclic antidepressant and serotonin reuptake inhibitor treatment. METHODS: In a multicentre part-randomised open-label study, 811 adult patients with moderate to severe unipolar depression were allocated to flexible dosage of escitalopram or nortriptyline for 12 weeks. The suicidality items of three standard measures were integrated in a suicidal ideation score. Increases in this score were classified as treatment emergent suicidal ideation (TESI) or treatment worsening suicidal ideation (TWOSI) according to the absence or presence of suicidal ideation at baseline. RESULTS: Suicidal ideation decreased during antidepressant treatment. Rates of TESI and TWOSI peaked in the fifth week. Severity of depression predicted TESI and TWOSI. In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively. Retirement and history of suicide attempts predicted TWOSI. CONCLUSION: Increases in suicidal ideation were associated with depression severity and decreased during antidepressant treatment. In men, treatment with escitalopram is associated with lower risk of suicidal ideation compared to nortriptyline. Clinicians should remain alert to suicidal ideation beyond the initial weeks of antidepressant treatment. TRIAL REGISTRATION: EudraCT (No.2004-001723-38) and ISRCTN (No. 03693000).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“SSRIs target serotonin, and appeared more effective than noradrenergic drugs for suicidal ideation.(59, 61)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [61]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More promisingly, antidepressants reduced suicidal ideation in 9/12 studies that reported effects on suicidal ideation.(55, 57, 59–65)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilevel and Longitudinal Modeling Using Stata
(2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00588_16.x · Cited by 4,236 · cited 9×
“Treatment worsening suicidal ideation (TWOSI) was defined as an increase of suicidal ideation of at least 0.5 SD above the individual's baseline score at any point during the study in individuals with significant suicidal ideation at baseline.”
Influential(2000) · Cited by 4,106
Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Davis, S. M., Harrison, W. M., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1445 · Cited by 702 · cited 1×
“As there are controversies about gender differences in antidepressant treatment response, it is warranted to investigate moderation of suicidal ideation during such treatment by gender [16].”
Family genetic studies, suicide, and suicidal behavior
Brent, D. A., & Mann, J. J. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30042 · Cited by 617 · cited 1×
“Another limitation is that our results could not be generalised to other forms of suicidal behaviours such as suicide attempts and suicide completion as the relationship between these phenomena has been shown to be imperfect [45].”
Gauderman, W. J., Morrison, J., & Morrison, W. M. (2006) · Medical Entomology and Zoology · Cited by 595
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Effect of Age at Onset on the Course of Major Depressive Disorder
Zisook, S., Lesser, I., Stewart, J. W., Wisniewski, S. R., Balasubramani, G. K., Fava, M., Gilmer, W. S., Dresselhaus, T. R., Thase, M. E., Nierenberg, A. A., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101757 · Cited by 548 · cited 1×
“This is consistent with several other studies [9,11,13,40].”
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510 · cited 12×
“In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively.”
InfluentialBech, P., Gram, L. F., Dein, E., Jacobsen, O., Vitger, J., & Bolwig, T. G. (1975) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1975.tb00002.x · Cited by 489
Gunnell, D., Saperia, J., & Ashby, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.385 · Cited by 387 · cited 3×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18,27-30], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Bondy, B., Buettner, A., & Zill, P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001803 · Cited by 319 · cited 1×
“As overactivity of the noradrenergic system is associated with anxiety and agitation, the increase in noradrenergic transmission induced by nortriptyline may drive the suicidal risk [37,38].”
Measuring depression: comparison and integration of three scales in the GENDEP study
Uher, R., Farmer, A., Maier, W., Rietschel, M., Hauser, J., Marusic, A., Mors, O., Elkin, A., Williamson, R. J., Schmael, C., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001730 · Cited by 293 · cited 8×
“We defined significant suicidal ideation as an IRT score of at least 1 SD above 0 (0 scores on all three scales corresponded to -0.425 on the standardised IRT θ scale; thus 0.575 or more is considered as significant suicidal ideation).”
InfluentialSelf-citationTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., & Haukka, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1358 · Cited by 277 · cited 1×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18,27-30], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Assessment and Treatment of Suicidal Patients
Hirschfeld, R. M. A., & Russell, J. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371307 · Cited by 271 · cited 1×
“These are known predictors of suicidal behaviours [33,43,44].”
Suicide and occupation: the impact of socio-economic, demographic and psychiatric differences
AGERBO, E., GUNNELL, D., BONDE, J. P., BO MORTENSEN, P., & NORDENTOFT, M. (2007) · Psychological Medicine · doi:10.1017/s0033291707000487 · Cited by 254 · cited 2×
“However, concordant with our findings, a recent study looking at risk factors for suicide among psychiatric patients found that marriage increased the suicide risk [44].”
Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., & Gunnell, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.389 · Cited by 240 · cited 11×
“In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively.”
InfluentialGenetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Laje, G., Paddock, S., Manji, H., Rush, A. J., Wilson, A. F., Charney, D., & McMahon, F. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06122018 · Cited by 213 · cited 7×
“Firstly, most of these studies used only one scale to measure suicidal ideation: a more sensitive selfreport questionnaire, risking false positives [9,12] or a more specific clinician-rated scale [10,11,13] risking false negatives.”
InfluentialAntidepressants and Suicide Risk in the United States, 1985–1999
Grunebaum, M. F., Ellis, S. P., Li, S., Oquendo, M. A., & Mann, J. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1103 · Cited by 186 · cited 1×
“These findings are in agreement with most epidemiological studies showing that mortality by suicide declines when antidepressant use increases [34-36].”
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression
Uher, R., Maier, W., Hauser, J., Marušič, A., Schmael, C., Mors, O., Henigsberg, N., Souery, D., Placentino, A., Rietschel, M., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057554 · Cited by 186 · cited 2×
“The sample comprised 811 subjects with major depressive disorder taking part in GENDEP, a partially randomised multicentre clinical and pharmacogenomic study [21].”
Self-citationBeasley, C. M., Ball, S. G., Nilsson, M. E., Polzer, J., Tauscher-Wisniewski, S., Plewes, J., & Acharya, N. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815abf21 · Cited by 184 · cited 1×
“The rates of TESI and TWOSI in GENDEP were higher than those reported previously [9-13,41].”
The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Juurlink, D. N., Mamdani, M. M., Kopp, A., & Redelmeier, D. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.813 · Cited by 174
Perlis, R. H., Purcell, S., Fava, M., Fagerness, J., Rush, A. J., Trivedi, M. H., & Smoller, J. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.689 · Cited by 148 · cited 7×
“Firstly, most of these studies used only one scale to measure suicidal ideation: a more sensitive selfreport questionnaire, risking false positives [9,12] or a more specific clinician-rated scale [10,11,13] risking false negatives.”
InfluentialValuck, R. J., Libby, A. M., Orton, H. D., Morrato, E. H., Allen, R., & Baldessarini, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010007 · Cited by 137 · cited 1×
“These warnings have had an impact on prescribing and may have paradoxically increased the risk of suicide in the population [8].”
Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants
Hammad, T. A., Laughren, T. P., & Racoosin, J. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203198.11453.95 · Cited by 128 · cited 1×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18, 27-30 ], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Antidepressant medication and suicide in Sweden
Carlsten, A., Waern, M., Ekedahl, A., & Ranstam, J. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.618 · Cited by 121 · cited 1×
“These findings are in agreement with most epidemiological studies showing that mortality by suicide declines when antidepressant use increases [34-36].”
Zisook, S., Trivedi, M. H., Warden, D., Lebowitz, B. D., Thase, M. E., Stewart, J. W., Moutier, C. Y., Fava, M., Wisniewski, S. R., Luther, J. F., et al. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.002 · Cited by 120 · cited 2×
“Male gender has also recently been associated with worsening of suicidal ideation during citalopram treatment [15].”
Suicide, depression, and antidepressants
Cipriani, A., Barbui, C., & Geddes, J. R. (2005) · BMJ · doi:10.1136/bmj.330.7488.373 · Cited by 102 · cited 1×
“As overactivity of the noradrenergic system is associated with anxiety and agitation, the increase in noradrenergic transmission induced by nortriptyline may drive the suicidal risk [37,38].”
Ruhé, H. G., Dekker, J., Peen, J., Holman, R., & de Jonghe, F. E. R. E. R. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.03.001 · Cited by 101 · cited 1×
“As there is imperfect correspondence in the content and number of response options between these three scales, and as no scale had been proven to be optimal by itself to measure depression severity or suicidal ideation [20, 24], we used the item response theory (IRT) graded response model to derive the best estimate o…”
Antidepressants and suicide mortality
Öhberg, A., Vuori, E., Klaukka, T., & Lönnqvist, J. K. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00114-1 · Cited by 92 · cited 1×
“These findings are in agreement with most epidemiological studies showing that mortality by suicide declines when antidepressant use increases [34-36].”
Mental disorders and suicide prevention
LÖNNQVIST, J. K., HENRIKSSON, M. M., SISOMETSÄ, E. T., MARTTUNEN, M. J., HEIKKINEN, M. E., ARO, H. M., & KUOPPASALMI, K. I. (1995) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1995.tb01912.x · Cited by 91 · cited 1×
“Mental disorders, especially depression, are present in more than 90% of suicides, and over 80% are untreated at the time of death [2, 3 ].”
Deliberate self-harm and antidepressant drugs: Investigation of a possible link
Donovan, S., Clayton, A., Beeharry, M., Jones, S., Kirk, C., Waters, K., Gardner, D., Faulding, J., & Madeley, R. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.551 · Cited by 78 · cited 11×
“In men, nortriptyline was associated with a 9.8-fold and 2.4-fold increase in TESI and TWOSI compared to escitalopram, respectively.”
InfluentialPerlis, R. H., Beasley Jr., C. M., Wines Jr., J. D., Tamura, R. N., Cusin, C., Shear, D., Amsterdam, J., Quitkin, F., Strong, R. E., Rosenbaum, J. F., et al. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000096363 · Cited by 78 · cited 8×
“Firstly, most of these studies used only one scale to measure suicidal ideation: a more sensitive selfreport questionnaire, risking false positives [9,12] or a more specific clinician-rated scale [10,11,13] risking false negatives.”
InfluentialHenriksson, S., Boëthius, G., & Isacsson, G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00276.x · Cited by 68
Szántó, K., Mulsant, B. H., Houck, P. R., Dew, M. A., Dombrovski, A. Y., Pollock, B. G., & Reynolds, C. F. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.015 · Cited by 65 · cited 9×
“The rates of TESI and TWOSI in GENDEP were higher than those reported previously [ 9-13 ,41].”
InfluentialHow have the SSRI antidepressants affected suicide risk?
Hall, W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68860-0 · Cited by 63 · cited 2×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18,27-30], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Suicide attempts in clinical trials with paroxetine randomised against placebo
Aursnes, I., Tvete, I. F., Gåsemyr, J., & Natvig, B. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-14 · Cited by 50 · cited 2×
“Several studies and meta-analyses found an increased risk of suicidal behaviours in adults treated with SSRIs compared with placebo and/or TCAs [4,5,18,27-30], but several other reports found no differences in suicidal behaviours between TCAs and SSRIs in adults [4,13,14,17,31-33].”
Suicidal Thinking and Behavior During Treatment With Sertraline in Late-Life Depression
Nelson, J. C., Delucchi, K., & Schneider, L. S. S. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318050c9c2 · Cited by 28 · cited 3×
“The incidence of treatment emergent suicidal ideation (TESI) varies from 4% to 20%, depending on the definition of suicidal ideation and sample characteristics [9-13].”
Balon, R. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000073025 · Cited by 18 · cited 1×
“It has been suggested that the highest risk of suicidal behaviour is in the initial few weeks or even days of treatment with antidepressants [11,13,14,42].”
Grayson, D. A., Bridges, K. W., Cook, D. J., & Goldberg, D. P. (1990) · Psychological Medicine · doi:10.1017/s0033291700013386 · Cited by 15
Mixed Depression, Suicidality, and Antidepressants
Benazzi, F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1024b · Cited by 12 · cited 1×
“It has been suggested that suicidal ideation is more common in agitated and irritable types of depression [39].”
Suicidality Scores During Double-Blind Fluoxetine and Desipramine Treatment in Mexican Americans
Sharma, A., Busnello, J. V., Ribeiro, L., Thakur, S., Whelan, F., Elashoff, R. M., Wong, M., & Licinio, J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e2d76 · Cited by 7
Cited by
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20060864 · Cited by 655
Britton, W. B., Lepp, N. E., Niles, H. F., Rocha, T., Fisher, N. E., & Gold, J. S. (2014) · Journal of School Psychology · doi:10.1016/j.jsp.2014.03.002 · Cited by 249
Is it valid to measure suicidal ideation by depression rating scales?
Desseilles, M., Perroud, N., Guillaume, S., Jaussent, I., Genty, C., Malafosse, A., & Courtet, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.013 · Cited by 208
“A couple of recent pharmacogenetic studies used the ‘suicide’ item of Hamilton's, Beck's or Montgomery–Asberg's depressive scale in order to assess the suicidal ideations associated with antidepressant treatment in the context of clinical trials (Perroud, 2011; Perroud et al., 2009a, 2009b, 2010).”
ResultSelf-citationGender differences in antidepressant drug response
Keers, R., & Aitchison, K. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.496448 · Cited by 185
“Specifically, men treated with nortriptyline were more likely to suffer from increasing suicidal ideation during treatment (Perroud et al., 2009).”
BackgroundSelf-citationUher, R., Mors, O., Rietschel, M., Rajewska-Rager, A., Petrovic, A., Zobel, A., Henigsberg, N., Mendlewicz, J., Aitchison, K. J., Farmer, A., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06419 · Cited by 156
Self-citation
Metadata
- Authors
- Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., Szczepankiewicz, A., Jorgensen, L., Strohmaier, J., Zobel, A., Giovannini, C., Elkin, A., Gunasinghe, C., Gray, J., Campbell, D., Gupta, B., Farmer, A. E., McGuffin, P., & Aitchison, K. J.
- Affiliations
- King's College London (GB)
- Central Institute of Mental Health (DE)
- Aarhus University Hospital (DK)
- University of Zagreb (HR)
- Poznan University of Medical Sciences (PL)
- University of Bonn (DE)
- Université Libre de Bruxelles (BE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- Corresponding author
- Perroud, Nader
- ORCID
- Venue
- BMC Medicine
- Published
- 2009-10-15
- Volume
- 7
- Issue
- 1
- Pages
- 60-60
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC2768737
- OpenAlex
- W2159946604
- Cited by
- 57
- References
- 41
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 3 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 9 · 2013: 2 · 2012: 5
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (118605)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- suicidal ideation, depression, escitalopram, nortriptyline, antidepressant treatment, tricyclic antidepressants, selective serotonin reuptake inhibitors, depression severity, suicide attempts, sex differences
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Tricyclic, Depressive Disorder, Female, Humans, Male, Middle Aged, Nortriptyline, Personality Inventory, Suicide, Citalopram, Selective Serotonin Reuptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.